Skip to content
Parakho

Tilaknagar Industries Ltd-$Q1 FY27 earnings call

· All quarters

Summary generated by AI from the official transcript Tilaknagar Industries Ltd-$ filed with BSE on 04 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries

The short read

Tilaknagar Industries reported Q1 FY27 net revenue growth of 166% YoY to Rs. 1,046 crore, driven by Imperial Blue volumes and continued integration of the acquired business. EBITDA rose 79% YoY to Rs. 169 crore, with margins under pressure from packaging cost inflation, particularly glass, partly offset by softer ENA prices. Management said 90% of Imperial Blue's business has been transitioned into Tilaknagar-operated units, with the remaining state expected to transition by March 2027.

Numbers mentioned

Net revenue: Rs. 1,046 crore (Q1 FY27)

p. 3
We witnessed a strong growth of 166% YoY basis to reach a net revenue of Rs. 1,046 crore during the quarter.

Amit Dahanukar, page 3 of the filed PDF · View the filing

Net revenue adjusted for subsidy: Rs. 1,026 crore (Q1 FY27)

p. 3
Adjusted for subsidy, we recorded a growth of 189% to reach Rs. 1,026 crore.

Amit Dahanukar, page 3 of the filed PDF · View the filing

Gross profit adjusted for subsidy: Rs. 432 crore (Q1 FY27)

p. 3
Adjusted for subsidy, we have achieved a gross profit of Rs. 432 crore in Q1 FY27 and a margin of 42.1% compared to 45.2% in Q4 FY26.

Amit Dahanukar, page 3 of the filed PDF · View the filing

EBITDA: Rs. 169 crore (Q1 FY27)

p. 3
EBITDA stood at Rs. 169 crore for Q1 FY27, clocking a growth of 79% YoY and margin of 16.1%.

Amit Dahanukar, page 3 of the filed PDF · View the filing

EBITDA adjusted for subsidy: Rs. 148 crore, 14.5% margin (Q1 FY27)

p. 3
Adjusted for subsidy, the EBITDA grew by 166% to reach Rs. 148 crore and a 14.5% margin on the combined business.

Amit Dahanukar, page 3 of the filed PDF · View the filing

PAT adjusted for exceptional items and amortization: Rs. 96 crore, 9.4% margin (Q1 FY27)

p. 3
PAT adjusted for exceptional items and acquisition-related amortization stood at Rs. 96 crore for Q1 FY27, clocking a growth of 9% YoY and margin of 9.4%.

Amit Dahanukar, page 3 of the filed PDF · View the filing

PAT adjusted for subsidy: Rs. 76 crore, 7.4% margin (Q1 FY27)

p. 3
Adjusted for subsidy, the PAT grew by 52% to reach Rs. 76 crore and a 7.4% margin on the combined business.

Amit Dahanukar, page 3 of the filed PDF · View the filing

Exceptional expense: Rs. 30 crore (Q1 FY27)

p. 4
We incurred an exceptional expense to the tune of Rs. 30 crore during Q1 FY27, predominantly on account of TSMA fees and integration-related expenses.

Amit Dahanukar, page 4 of the filed PDF · View the filing

Gross debt: Rs. 2,241 crore (as on 30th June 2026)

p. 4
As on 30th June 2026, our gross debt stood at Rs. 2,241 crore and net debt stood at Rs. 2,100 crore.

Amit Dahanukar, page 4 of the filed PDF · View the filing

Net debt: Rs. 2,100 crore (as on 30th June 2026)

p. 4
As on 30th June 2026, our gross debt stood at Rs. 2,241 crore and net debt stood at Rs. 2,100 crore.

Amit Dahanukar, page 4 of the filed PDF · View the filing

Overall NSR: Rs. 1,183 per case (Q1 FY27)

p. 3
The overall NSR increased by 1.5% to Rs. 1,183 per case for Q1 FY27 from Rs. 1,166 per case in Q4 FY26 and by 5.3% from Rs. 1,123 per case in Q1 FY26.

Amit Dahanukar, page 3 of the filed PDF · View the filing

Overall volume growth: 172% YoY, 9% QoQ (Q1 FY27)

p. 3
In Q1, our overall volumes increased by 172% on a YoY basis and 9% on a QoQ basis.

Amit Dahanukar, page 3 of the filed PDF · View the filing

IB volume: 5.4 million cases, up 18% (Q1 FY27)

p. 3
The quarterly growth was led primarily by IB, which increased by 18% to reach 5.4 million cases.

Amit Dahanukar, page 3 of the filed PDF · View the filing

Highest ever monthly volume: 3.4 million cases (June 2026)

p. 2
we achieved the highest ever monthly volume of 3.4 million cases in June'26 with Imperial Blue emerging as the largest selling Deluxe Whisky.

Amit Dahanukar, page 2 of the filed PDF · View the filing

What management said it would do

A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.

Net debt — approximately Rs. 1,700 crore · March 2027

stated firmly by Amit Dahanukar

p. 4
I want to reassure you that our target is to take the net debt in March '27 to approximately Rs. 1,700 crore.

Amit Dahanukar, page 4 of the filed PDF · View the filing

EBITDA margin — 16%-18% on combined business · next 2 years

stated as an aspiration by Amit Dahanukar

p. 4
Optimize packaging, processes and supply chain and reap benefits of operating leverage and economies of scale, helping us achieve an EBITDA margin of 16%-18% on combined business in the next 2 years

Amit Dahanukar, page 4 of the filed PDF · View the filing

Net debt-to-EBITDA — below 1.0x · FY29

stated firmly by Amit Dahanukar

p. 4
Focus on efficient capital deployment, disciplined debt management and working capital investments, facilitating the reduction of net debt-to-EBITDA below 1.0x by FY29

Amit Dahanukar, page 4 of the filed PDF · View the filing

IB TSMA transition — remaining state transitioned · outer date of March 2027

stated firmly by Ameya Deshpande

p. 5
Now only 1 state remains under TSMA, and we expect to transition them over the course of the next few quarters with an outer date of March 2027.

Ameya Deshpande, page 5 of the filed PDF · View the filing

Volume growth — high single-digit to low double-digit · FY27

stated firmly by Ameya Deshpande

p. 5
We maintain our guidance for FY27 of achieving a high single-digit to low double￾digit volume growth for the combined business.

Ameya Deshpande, page 5 of the filed PDF · View the filing

Annual volume growth — mid-teens · next couple of years

stated as an aspiration by Ameya Deshpande

p. 5
We expect an annual volume growth in mid-teens over the next couple of years, and our revenues are expected to grow at least by ~300 basis points higher than the volume growth.

Ameya Deshpande, page 5 of the filed PDF · View the filing

Consolidated EBITDA margin — 16%-18% for combined business · FY29

stated as an aspiration by Ameya Deshpande

p. 5
In terms of margins, we expect the consolidated EBITDA margins to reach 16%-18% for the combined business by FY29 with upward bias on the range.

Ameya Deshpande, page 5 of the filed PDF · View the filing

EBITDA margin — improve from base of 15.5% · FY27

stated firmly by Ameya Deshpande

p. 5
For FY27, we expect our margin to improve from the base of 15.5% set in Q4 FY26.

Ameya Deshpande, page 5 of the filed PDF · View the filing

Net debt-to-EBITDA — below 1.0x · March 2029

stated firmly by Ameya Deshpande

p. 5
As guided in the past as well, we expect the net debt-to-EBITDA ratio going below 1.0x by March’29.

Ameya Deshpande, page 5 of the filed PDF · View the filing

Imperial Blue Delhi volume — 0.5 million cases · next 12 to 18 months

stated as an aspiration by Amit Dahanukar

p. 7
Delhi, I think at the peak, the volume of Imperial Blue would have been 0.5 million cases, and we expect that within the next 12 to 18 months, we should be seeing those levels.

Amit Dahanukar, page 7 of the filed PDF · View the filing

IB full year volume growth — double-digit · FY27

stated firmly by Amit Dahanukar

p. 10
For the full year, it will be a double-digit growth. I think when we acquired the business, it was around 21.5 million cases.

Amit Dahanukar, page 10 of the filed PDF · View the filing

Telangana price increase — soon

stated conditionally by Amit Dahanukar

p. 10
We are in active discussions. The industry is engaged with the government, and we do expect price increase to happen soon.

Amit Dahanukar, page 10 of the filed PDF · View the filing

Margin impact from Telangana price rise — 150-200 basis points · annualized

stated conditionally by Ameya Deshpande

p. 10
And in terms of quantifying what the impact of this price increase would be, it would be in the range of 150-200 basis points incremental impact on margins, on an annualized basis.

Ameya Deshpande, page 10 of the filed PDF · View the filing

Net debt reduction — approximately Rs. 400 crore · FY27

stated firmly by Amit Dahanukar

p. 12
So, there is a clear intent of reducing debt by approximately Rs. 400 crore in this financial year.

Amit Dahanukar, page 12 of the filed PDF · View the filing

Margin expansion on acquired business — 250-400 basis points

stated firmly by Ameya Deshpande

p. 12
All of these will essentially lead to a scenario where we will expand our margins on the acquired business between 250- 400 basis points irrespective.

Ameya Deshpande, page 12 of the filed PDF · View the filing

Margin expansion on consolidated business — approximately 250 basis points

stated firmly by Ameya Deshpande

p. 13
And when it comes to our consolidated business, we would be expanding our margins by approximately 250-odd basis points.

Ameya Deshpande, page 13 of the filed PDF · View the filing

Volume growth with new launches — mid-double digit, CAGR mid-teens · till FY29

stated as an aspiration by Amit Dahanukar

p. 9
And with the new launches in place, we expect the volume growth to be in mid-double digit. We will have a CAGR of mid-teens till FY29.

Amit Dahanukar, page 9 of the filed PDF · View the filing

Q&A highlights

Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.

Management said Karnataka saw a good uptake in volumes and improved market share after the price reduction, and said improvements were seen across all states without exception, with South being an easier transition.

Answered by Amit Dahanukar

Asked by Abneesh Roy: Which states are seeing more traction versus challenges for IB, and how has Karnataka competition shaped up post reforms?

p. 6
On Karnataka post price reduction, we have seen a good uptake in our volumes since the price reduction has taken place. And our market shares also have significantly improved in the operating segment.

Amit Dahanukar, page 6 of the filed PDF · View the filing

Management said the team scale-up was completed, growing from about 350 to 850+ people, and that Delhi IB volumes could reach the historic peak of 0.5 million cases within 12-18 months.

Answered by Amit Dahanukar

Asked by Abneesh Roy: What is the peak market share/size expectation for IB in Delhi and has team scale-up across India been completed?

p. 7
The team scale up, Abneesh, has been totally completed. I think pre acquisition, our strength was approximately 350 people. As on March 31, it was 850+ people.

Amit Dahanukar, page 7 of the filed PDF · View the filing

Management confirmed the disruptions were related to TSMA issues specific to IB and declined to detail the individual causes.

Answered by Ameya Deshpande

Asked by Nitin Gupta: Were the disruptions in Odisha, Punjab, Uttarakhand and Karnataka limited to IB, and what caused them?

p. 8
See, Nitin, when it comes to the question, yes, it was predominantly for IB itself because we have mentioned over there that these were TSMA-related issues, TSMA was only relevant for IB.

Ameya Deshpande, page 8 of the filed PDF · View the filing

Management said Q3 and Q4 would show significant margin uptick due to seasonality, while Q2 margins would stay in a similar range due to incremental A&SP reinvestment.

Answered by Ameya Deshpande

Asked by Nitin Gupta: How soon can the company recover to the 15.5% EBITDA margin baseline given packaging inflation?

p. 8
in Q3 and Q4 is when you will see significant uptick in margins because from a seasonality perspective, those are the largest quarters from a saliency.

Ameya Deshpande, page 8 of the filed PDF · View the filing

Management said they expect a price increase soon given active industry discussions with the government, three years after the last increase.

Answered by Amit Dahanukar

Asked by Heer Gogri: Is a price rise expected from Telangana?

p. 10
Price rise from Telangana, we are expecting because now it has been 3 years since the earlier price increase was given. We are in active discussions.

Amit Dahanukar, page 10 of the filed PDF · View the filing

Management said around 60-70% of the expected benefit is already baked into the numbers, with more still to come.

Answered by Ameya Deshpande

Asked by Vijay Jangir: Are cost savings from Prag Distillery reflecting in Q1 FY27 margins, and what is the current utilization?

p. 10
Yes. So, you have not seen the entire benefit of the bottling coming into Prag Distilleries, but what is already baked into the numbers would be to the tune of around 60%-70%.

Ameya Deshpande, page 10 of the filed PDF · View the filing

Management said Tamil Nadu is currently a small market for them (less than 0.5 million cases annualized) but is the largest brandy market in India, and they are watching for policy changes under the new government.

Answered by Amit Dahanukar

Asked by Vaibhav Gupta: How significant is the Tamil Nadu market and how would a route-to-market change impact the company?

p. 11
Currently, the Tamil Nadu business is not very large for us. I think annualized, it would be less than 0.5 million cases.

Amit Dahanukar, page 11 of the filed PDF · View the filing

Management named the completed integration, widening and deepening IB distribution while reinvesting in A&SP, and building out the Luxury business as the three priorities.

Answered by Amit Dahanukar

Asked by Sucrit Patil: What are the top execution priorities for the coming quarters and the biggest risks in consumer demand or competition?

p. 12
The immediate priorities are in terms of widening and deepening the distribution of Imperial Blue and reinvesting in A&SP so that our market shares can climb.

Amit Dahanukar, page 12 of the filed PDF · View the filing

Management identified raw material inflation as a key risk being watched, with price increases and supply chain optimization cited as mitigating factors.

Answered by Rajesh Choudhary

Asked by Sucrit Patil: What financial risks does the company anticipate and how is it managing margins, cash flow and balance sheet strength?

p. 12
The inflation is something that is to be watched out. And obviously, we have called out that in the Q1, it has some impact.

Rajesh Choudhary, page 12 of the filed PDF · View the filing

Risks flagged

Inflationary pressure on packaging inputs, particularly glass, due to geopolitical tensions

p. 3
The ongoing geopolitical tensions led to inflationary pressures across packaging inputs, particularly glass, resulting in a meaningful increase in packaging costs during the quarter.

Amit Dahanukar, page 3 of the filed PDF · View the filing

TSMA-related disruptions affecting IB in certain states

p. 8
See, Nitin, when it comes to the question, yes, it was predominantly for IB itself because we have mentioned over there that these were TSMA-related issues, TSMA was only relevant for IB.

Ameya Deshpande, page 8 of the filed PDF · View the filing

Increased competitive intensity in the low Prestige whisky segment

p. 8
I think this competitive intensity, which you have mentioned that is absolutely correct. I think this segment after a long time is seeing the activity.

Amit Dahanukar, page 8 of the filed PDF · View the filing

Raw material cost volatility remains a risk to be monitored

p. 12
The inflation is something that is to be watched out. And obviously, we have called out that in the Q1, it has some impact.

Rajesh Choudhary, page 12 of the filed PDF · View the filing

Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.